TY - JOUR
T1 - Sepsis in silico
T2 - definition, development and application of an electronic phenotype for sepsis
AU - Al-Sultani, Zahraa
AU - Inglis, Timothy J.J.
AU - McFadden, Benjamin
AU - Thomas, Elizabeth
AU - Reynolds, Mark
N1 - Publisher Copyright:
© 2025 The Authors.
PY - 2025/3/28
Y1 - 2025/3/28
N2 - Repurposing electronic health record (EHR) or electronic medical record (EMR) data holds significant promise for evidence-based epidemic intelligence and research. Key challenges include sepsis recognition by physicians and issues with EHR and EMR data. Recent advances in data-driven techniques, alongside initiatives like the Surviving Sepsis Campaign and the Severe Sepsis and Septic Shock Management Bundle (SEP-1), have improved sepsis definition, early detection, subtype characterization, prognostication and personalized treatment. This includes identifying potential biomarkers or digital signatures to enhance diagnosis, guide therapy and optimize clinical management. Machine learning applications play a crucial role in identifying biomarkers and digital signatures associated with sepsis and its sub-phenotypes. Additionally, electronic phenotyping, leveraging EHR and EMR data, has emerged as a valuable tool for evidence-based sepsis identification and management. This review examines methods for identifying sepsis cohorts, focusing on two main approaches: utilizing health administrative data with standardized diagnostic coding via the International Classification of Diseases and integrating clinical data. This overview provides a comprehensive analysis of current cohort identification and electronic phenotyping strategies for sepsis, highlighting their potential applications and challenges. The accuracy of an electronic phenotype or signature is pivotal for precision medicine, enabling a shift from subjective clinical descriptions to data-driven insights.
AB - Repurposing electronic health record (EHR) or electronic medical record (EMR) data holds significant promise for evidence-based epidemic intelligence and research. Key challenges include sepsis recognition by physicians and issues with EHR and EMR data. Recent advances in data-driven techniques, alongside initiatives like the Surviving Sepsis Campaign and the Severe Sepsis and Septic Shock Management Bundle (SEP-1), have improved sepsis definition, early detection, subtype characterization, prognostication and personalized treatment. This includes identifying potential biomarkers or digital signatures to enhance diagnosis, guide therapy and optimize clinical management. Machine learning applications play a crucial role in identifying biomarkers and digital signatures associated with sepsis and its sub-phenotypes. Additionally, electronic phenotyping, leveraging EHR and EMR data, has emerged as a valuable tool for evidence-based sepsis identification and management. This review examines methods for identifying sepsis cohorts, focusing on two main approaches: utilizing health administrative data with standardized diagnostic coding via the International Classification of Diseases and integrating clinical data. This overview provides a comprehensive analysis of current cohort identification and electronic phenotyping strategies for sepsis, highlighting their potential applications and challenges. The accuracy of an electronic phenotype or signature is pivotal for precision medicine, enabling a shift from subjective clinical descriptions to data-driven insights.
KW - bloodstream infection
KW - digital phenotype
KW - machine learning
KW - precision medicine
KW - sepsis
UR - http://www.scopus.com/inward/record.url?scp=105001269786&partnerID=8YFLogxK
U2 - 10.1099/jmm.0.001986
DO - 10.1099/jmm.0.001986
M3 - Article
C2 - 40153307
AN - SCOPUS:105001269786
SN - 0022-2615
VL - 74
SP - 1
EP - 11
JO - Journal of Medical Microbiology
JF - Journal of Medical Microbiology
IS - 3
M1 - 001986
ER -